IMI—Bigpicture: A Central Repository for Digital Pathology

34Citations
Citations of this article
69Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

To address the challenges posed by large-scale development, validation, and adoption of artificial intelligence (AI) in pathology, we have constituted a consortium of academics, small enterprises, and pharmaceutical companies and proposed the BIGPICTURE project to the Innovative Medicines Initiative. Our vision is to become the catalyst in the digital transformation of pathology by creating the first European, ethically compliant, and quality-controlled whole slide imaging platform, in which both large-scale data and AI algorithms will exist. Our mission is to develop this platform in a sustainable and inclusive way, by connecting the community of pathologists, researchers, AI developers, patients, and industry parties based on creating value and reciprocity in use based on a community model as the mechanism for ensuring sustainability of the platform.

Cite

CITATION STYLE

APA

Moulin, P., Grünberg, K., Barale-Thomas, E., & der Laak, J. van. (2021). IMI—Bigpicture: A Central Repository for Digital Pathology. Toxicologic Pathology, 49(4), 711–713. https://doi.org/10.1177/0192623321989644

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free